Ledipasvir / sofosbuvir Alternatives Compared
| Ledipasvir / sofosbuvir | Harvoni (ledipasvir / sofosbuvir) | Ribavirin |
|
|---|
| Ledipasvir / sofosbuvir | Harvoni (ledipasvir / sofosbuvir) | Ribavirin |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hepatitis C. Ledipasvir / sofosbuvir may also be used for purposes not listed in this medication guide. |
Prescription only
Harvoni is a combination tablet containing ledipasvir and sofosbuvir. It may be used to treat certain genotypes of the hepatitis C virus in adults and children over the age of three. It is usually... View more |
Prescription only
Prescribed for Hepatitis C, RSV. Ribavirin may also be used for purposes not listed in this medication guide. |
Related suggestions Hepatitis C
|
|||||||||||||||||||||||
| More about Ledipasvir / sofosbuvir | More about Harvoni (ledipasvir / sofosbuvir) | More about Ribavirin | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Ledipasvir / sofosbuvir has an average rating of 8.3 out of 10 from a total of 412 ratings on Drugs.com. 77% of reviewers reported a positive effect, while 11% reported a negative effect. |
Harvoni has an average rating of 8.4 out of 10 from a total of 403 ratings on Drugs.com. 78% of reviewers reported a positive effect, while 11% reported a negative effect. |
Ribavirin has an average rating of 4.8 out of 10 from a total of 10 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Ledipasvir / sofosbuvir side effects |
View all Harvoni side effects |
View all Ribavirin side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Ledipasvir / sofosbuvir prices |
View all Harvoni prices |
View all Ribavirin prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Harvoni |
N/A |
Rebetol, RibaTab, Virazole | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
47 hours |
47 hours |
960 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 179 drugs are known to interact with Ledipasvir / sofosbuvir:
|
A total of 179 drugs are known to interact with Harvoni:
|
A total of 18 drugs are known to interact with Ribavirin:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
October 10, 2014 |
October 10, 2014 |
June 03, 1998 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.